-
Amyloid Beta-peptide (25-35) Neurotoxicity Model
2026-09-12
Amyloid Beta-peptide (25-35), also called Aβ25-35, is a synthetic human amyloid beta fragment used as a compact Alzheimer's disease neurotoxicity model. It supports controlled studies of neuronal injury, oxidative stress, amyloid aggregation, and microglial inflammatory signaling.
-
Butylated Hydroxyanisole (BHA) Assay Workflows
2026-09-11
Build more interpretable oxidative stress experiments with Butylated hydroxyanisole (BHA), using controlled solvent, timing, and orthogonal readouts. This workflow treats BHA as a redox perturbation tool rather than a universal rescue reagent, helping distinguish ROS changes from downstream effects on viability, apoptosis, or inflammation.
-
CHI3L1-IN-5 Workflow for Neuroinflammation
2026-09-11
CHI3L1-IN-5, also called Compound Z17, combines CNS-relevant exposure characteristics with a focused strategy for probing CHI3L1-driven inflammation. This workflow connects NF-κB signaling, astrocyte Aβ uptake, and lysosomal endpoints while separating product-backed findings from practical assay starting conditions.
-
GSK621: AMPK Agonist at the AML Frontier
2026-09-10
GSK621 offers translational researchers a potent AMPK agonist for connecting energy sensing with AML biology, apoptosis, autophagy, and immunometabolic questions. This article integrates AML evidence with the 25-hydroxycholesterol–AMPK macrophage axis while distinguishing established findings from testable hypotheses.
-
TerminaTOR Maps Nuclear mTORC1 Transcriptional Control
2026-09-10
The reference study introduces TerminaTOR, a genetically encodable inhibitor that can selectively perturb mTORC1 at defined subcellular locations. By contrasting lysosomal and nuclear inhibition, the work shows that nuclear mTORC1 regulates transcription of CCAAT motif-containing genes, revealing functional spatial compartmentalization beyond canonical nutrient signaling.
-
Heterologous Regulators Improve Teicoplanin and A40926
2026-09-09
Zhukrovska and colleagues show that StrR-like regulatory proteins can act across phylogenetically distant antibiotic biosynthetic pathways. Heterologous expression of chers28 improved teicoplanin and A40926 production, whereas ramo5 did not, highlighting regulatory cross-talk as a selective strategy for activating or optimizing biosynthetic gene clusters.
-
Baicalin Methyl Ester for Intestinal Barrier Studies
2026-09-09
Baicalin methyl ester is an esterified derivative of baicalin suited to mechanistic studies of LPS-induced intestinal barrier damage. Its value lies in pairing cytokine suppression with tight-junction restoration across MODE-K cell and mouse workflows.
-
Viperin Targets Coronavirus nsp8 to Block Replication
2026-09-08
The reference study identifies a previously unrecognized anti-coronavirus mechanism in which viperin binds nsp8, disrupts replication-transcription complex assembly, and reduces viral RNA polymerase activity. Using porcine deltacoronavirus as a model, the work separates this protein-interaction mechanism from ddhCTP-mediated chain termination and suggests a possible basis for broader antiviral drug development.
-
Bortezomib (PS-341) and the PDAR Apoptosis Axis
2026-09-08
Bortezomib (PS-341) is a reversible 20S proteasome inhibitor that provides a powerful entry point for dissecting proteostasis-driven cell death. This article connects proteasome perturbation with the 2025 discovery of Pol II degradation-dependent apoptosis while defining practical assays that distinguish target engagement from downstream mitochondrial signaling.
-
ML216: BLM Helicase Inhibitor Research Workflow
2026-09-07
ML216 enables controlled interrogation of BLM-dependent DNA repair, homologous recombination, sister chromatid exchange, and chemotherapy response. This practical guide connects biochemical testing with paired cellular models while clearly distinguishing BLM-focused experiments from WRN–MSI findings in colorectal cancer.
-
Phosbind Acrylamide: Read Phosphorylation in Context
2026-09-05
Phosbind Acrylamide enables antibody-free SDS-PAGE phosphorylation detection through phosphorylation-dependent mobility shifts. This guide connects assay design with the OsANN4 ABA-signaling study, showing how to interpret gel shifts alongside calcium, ROS, and kinase evidence.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-09-05
The reference study shows that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis by maintaining epithelial barrier function and controlling gut–liver lipid signaling. Conditional loss of Tm6sf2 caused dysbiosis, increased lysophosphatidic acid transfer to the liver, and hepatic inflammation, while microbiota manipulation or LPA receptor inhibition reduced disease features.
-
TRPV1/TRPA1 Control of TSLP in Nasal Epithelium
2026-09-04
The reference study identifies a calcium-dependent TRPV1/TRPA1–NFAT pathway that links temperature-sensitive ion-channel activation in nasal epithelial cells to TSLP production and upper-airway inflammatory signaling. Its use of calcium chelation, channel antagonism, gene silencing, cytokine profiling, and NFAT localization provides a useful framework for connecting acute TRPA1 ion channel modulation with epithelial immune responses.
-
Pifithrin-α: Mapping p53 in Ferroptosis
2026-09-04
Pifithrin-α is a practical p53 inhibitor for separating p53-dependent apoptosis, ferroptosis, and cell-cycle responses in stress models. This article translates recent developmental neurotoxicity findings into a rigorous assay-design framework while defining controls, formulation choices, and interpretation limits.
-
N2703 in Adipose–Neural Cardiac Models
2026-09-03
Learn how to deploy 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled perturbagen in adipocyte–sympathetic neuron–cardiomyocyte assays. The workflow emphasizes compartment-specific dosing, electrophysiology controls, and troubleshooting rather than assuming an unverified molecular target.